Evidence map›Paper›PMID 39148557›Full record

ArticleThe European physical journal. D, Atomic, molecular, and optical physics2019

Renormalization of radiobiological response functions by energy loss fluctuations and complexities in chromosome aberration induction: deactivation theory for proton therapy from cells to tumor control.

Ramin Abolfath, Yusuf Helo, Lawrence Bronk, Alejandro Carabe, David Grosshans, Radhe Mohan

Abstract read
In one paragraph

Article in The European physical journal. D, Atomic, molecular, and optical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramin AbolfathDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 75031, USA.
Yusuf HeloInvicro, A Konica Minolta Company, London, UK.
Lawrence BronkDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 75031, USA.
Alejandro CarabeDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.
David GrosshansDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 75031, USA.
Radhe MohanDepartment of Radiation Physics and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 75031, USA.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2021 to 2025
$14.0M
MDACC Clinical and Research Physics SupportU19CA021239 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MOHAN, RADHE · 2014 to 2018
$11.2M
NCI NIH HHS P01 CA261669NCI NIH HHS P30 CA016672NCI NIH HHS U19 CA021239
6 · The paper itself

Abstract

We employ a multi-scale mechanistic approach built upon our recent phenomenological/computational methodologies [R. Abolfath et al., Sci. Rep.

Identifiers

PMID39148557
PMCPMC11325099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.